Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

BridgeBio Pharma (BBIO) Return on Invested Capital (2025)

BridgeBio Pharma's Return on Invested Capital history spans 1 years, with the latest figure at 196.92% for Q4 2025.

  • For Q4 2025, Return on Invested Capital changed N/A year-over-year to 196.92%; the TTM value through Dec 2025 reached 196.92%, changed N/A, while the annual FY2025 figure was 1.3%, 72.0% up from the prior year.
  • Return on Invested Capital for Q4 2025 was 196.92% at BridgeBio Pharma.
  • Across five years, Return on Invested Capital topped out at 196.92% in Q4 2025 and bottomed at 196.92% in Q4 2025.